Stock listing
HKEX:2652 CF PharmTech. Inc. (長風藥業) 股價
Follow CF PharmTech. Inc. into a list and get an email when it puts out news.
Share price · HKEX:2652
$4.22 HKD -0.21 (-4.8%)
Close on Nov 20, 2026
- Day range
- $4.16 – $4.45 HKDNov 20, 2026
- Volume
- 1.32M sharesNov 20, 2026
- Market cap
- $1.36B HKDAt the close on Nov 20, 2026 · price × 322.4M shares outstanding
- 52-week range
- $4.16 – $39.50 HKDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $25.24M HKDMedian day 1.87M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · HKEX:2652 · HKD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $4.22 | -0.215 | -4.8% | $4.395 | $4.45 | $4.16 | 1,318,384 | |
| $4.435 | -0.21 | -4.5% | $4.525 | $4.69 | $4.29 | 936,300 | |
| $4.645 | +0.055 | +1.2% | $4.75 | $4.75 | $4.515 | 874,707 | |
| $4.59 | -0.25 | -5.2% | $4.84 | $4.84 | $4.495 | 1,106,148 | |
| $4.84 | -0.24 | -4.7% | $5.10 | $5.105 | $4.84 | 835,600 | |
| $5.08 | -0.12 | -2.3% | $5.19 | $5.225 | $5.065 | 767,900 | |
| $5.20 | +0.015 | +0.3% | $5.29 | $5.295 | $5.11 | 1,037,100 | |
| $5.185 | +0.145 | +2.9% | $5.02 | $5.26 | $5.02 | 863,900 | |
| $5.04 | -0.12 | -2.3% | $5.245 | $5.335 | $5.005 | 1,075,100 | |
| $5.16 | -0.315 | -5.8% | $5.47 | $5.49 | $5.155 | 1,011,800 | |
| $5.475 | +0.19 | +3.6% | $5.32 | $5.58 | $5.30 | 1,944,100 | |
| $5.285 | +0.215 | +4.2% | $4.95 | $5.325 | $4.93 | 1,227,207 | |
| $5.07 | -0.215 | -4.1% | $5.08 | $5.24 | $4.935 | 1,881,675 | |
| $5.285 | -0.015 | -0.3% | $5.30 | $5.30 | $5.115 | 713,143 | |
| $5.30 | -0.33 | -5.9% | $5.76 | $5.775 | $5.27 | 1,007,900 | |
| $5.63 | -0.005 | -0.1% | $5.635 | $5.875 | $5.55 | 1,142,875 | |
| $5.635 | +0.01 | +0.2% | $5.62 | $5.77 | $5.57 | 539,546 | |
| $5.625 | +0.015 | +0.3% | $5.555 | $5.68 | $5.53 | 396,974 | |
| $5.61 | +0.015 | +0.3% | $5.35 | $5.65 | $5.35 | 390,245 | |
| $5.595 | +0.165 | +3.0% | $5.43 | $5.595 | $5.33 | 792,083 | |
| $5.43 | -0.325 | -5.6% | $5.755 | $5.755 | $5.375 | 1,075,343 | |
| $5.755 | -0.075 | -1.3% | $5.86 | $6.025 | $5.625 | 1,257,800 | |
| $5.83 | -0.15 | -2.5% | $6.15 | $6.15 | $5.805 | 1,497,800 | |
| $5.98 | +0.07 | +1.2% | $6.15 | $6.15 | $5.77 | 1,957,000 | |
| $5.91 | -0.265 | -4.3% | $6.035 | $6.25 | $5.91 | 2,289,100 | |
| $6.175 | -0.175 | -2.8% | $6.405 | $6.505 | $6.045 | 4,992,300 | |
| $6.35 | +0.23 | +3.8% | $6.00 | $6.69 | $5.91 | 7,910,300 | |
| $6.12 | +0.065 | +1.1% | $6.235 | $6.325 | $5.88 | 2,415,200 | |
| $6.055 | +0.305 | +5.3% | $5.75 | $6.43 | $5.575 | 10,319,300 | |
| $5.75 | -0.89 | -13.4% | $6.64 | $6.645 | $5.175 | 25,334,504 | |
| $6.64 | -0.245 | -3.6% | $6.80 | $6.88 | $6.35 | 996,400 | |
| $6.885 | -0.275 | -3.8% | $7.175 | $7.175 | $6.805 | 434,100 | |
| $7.16 | +0.31 | +4.5% | $7.18 | $7.30 | $6.655 | 625,300 | |
| $6.85 | -0.085 | -1.2% | $7.30 | $7.30 | $6.85 | 400,200 | |
| $6.935 | -0.05 | -0.7% | $7.06 | $7.15 | $6.51 | 2,613,100 | |
| $6.985 | -0.305 | -4.2% | $7.305 | $7.49 | $6.92 | 3,160,600 | |
| $7.29 | -2.20 | -23.2% | $9.49 | $9.49 | $7.265 | 5,086,900 | |
| $9.49 | +0.115 | +1.2% | $9.375 | $9.55 | $9.07 | 250,800 | |
| $9.375 | -0.01 | -0.1% | $9.285 | $9.73 | $9.21 | 1,983,600 | |
| $9.385 | -0.915 | -8.9% | $10.33 | $10.38 | $9.32 | 2,711,000 | |
| $10.30 | -0.70 | -6.4% | $11.29 | $11.29 | $9.985 | 1,632,500 | |
| $11.00 | 0.00 | 0.0% | $10.77 | $11.28 | $10.68 | 1,855,900 | |
| $11.00 | +0.37 | +3.5% | $10.63 | $11.30 | $10.63 | 2,071,300 | |
| $10.63 | +0.25 | +2.4% | $10.48 | $10.78 | $10.23 | 1,268,200 | |
| $10.38 | +0.32 | +3.2% | $10.06 | $10.65 | $9.87 | 1,988,000 | |
| $10.06 | -0.06 | -0.6% | $9.82 | $10.70 | $9.82 | 2,075,800 | |
| $10.12 | -0.24 | -2.3% | $10.45 | $11.49 | $9.94 | 4,586,400 | |
| $10.36 | +0.76 | +7.9% | $9.695 | $10.65 | $9.605 | 5,751,050 | |
| $9.60 | +0.315 | +3.4% | $9.285 | $9.80 | $8.88 | 3,535,000 | |
| $9.285 | -0.685 | -6.9% | $10.08 | $10.09 | $9.20 | 2,488,600 | |
| $9.97 | -0.37 | -3.6% | $10.34 | $10.50 | $9.91 | 2,032,700 | |
| $10.34 | -0.66 | -6.0% | $10.88 | $10.92 | $10.14 | 3,609,700 | |
| $11.00 | -0.80 | -6.8% | $12.05 | $12.05 | $10.92 | 3,185,900 | |
| $11.80 | -0.90 | -7.1% | $12.72 | $12.80 | $11.75 | 2,449,600 | |
| $12.70 | -1.10 | -8.0% | $13.98 | $13.98 | $12.70 | 1,857,900 | |
| $13.80 | -0.29 | -2.1% | $14.30 | $14.32 | $13.79 | 1,296,000 | |
| $14.09 | -0.42 | -2.9% | $14.63 | $14.63 | $13.36 | 2,206,300 | |
| $14.51 | -0.87 | -5.7% | $15.38 | $15.66 | $14.15 | 4,495,200 | |
| $15.38 | +0.07 | +0.5% | $15.49 | $18.66 | $15.36 | 11,403,700 | |
| $15.31 | -0.32 | -2.0% | $15.63 | $15.96 | $15.29 | 1,284,100 | |
| $15.63 | +0.42 | +2.8% | $16.78 | $19.00 | $15.40 | 9,570,100 | |
| $15.21 | +0.01 | +0.1% | $15.25 | $15.35 | $15.00 | 3,104,000 | |
| $15.20 | -0.67 | -4.2% | $15.91 | $16.05 | $15.19 | 2,773,800 | |
| $15.87 | -0.53 | -3.2% | $16.40 | $16.79 | $15.87 | 3,213,200 |
- Ticker
- HKEX:2652
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- HKEX
- Currency
- HKD
What changed lately
Latest news release · Nov 4, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Latest news
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Nov 4, 2026
Closed $5.48 (+3.6%) on Nov 5, 2026
Next day disclosure return
Oct 8, 2026
Closed $6.06 (+5.3%) on Oct 9, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Oct 6, 2026
Closed $6.64 (-3.6%) on Oct 7, 2026
Voluntary announcement voluntary extension of lock-up period for shares held by core management by six months
Oct 5, 2026
Closed $6.89 (-3.8%) on Oct 6, 2026
2026 Interim Report
Sep 30, 2026
Closed $6.85 (-1.2%) on Oct 2, 2026
Voluntary announcement ICF004 completes enrolment and dosing of first healthy volunteer in phase i clinical trial
Sep 21, 2026
Closed $10.30 (-6.4%) on Sep 22, 2026
List of Directors and their Roles and Functions
Jun 26, 2026
Closed $18.98 (+2.5%) on Jun 29, 2026
Change in board lot size
Jun 22, 2026
Closed $18.76 (-0.1%) on Jun 23, 2026
CF PharmTech. Inc. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 16 in the last 12 months · 16 in all · newest Nov 4, 2026 · oldest 2026
Valuation
P/E 466× against a median of 23.3×: the highest of 11 Pharmaceuticals companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $899.1M HKD
- P/E
- 466×
- EV/sales
- 1.8×
- EV/EBITDA
- 12.4×
- Price/book
- 0.9×
- Gross margin
- 75.8%
- Operating margin
- −1.6%
- Net margin
- 0.6%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| CF PharmTech. Inc. Class H · HKEX:2652 | US$173.6M | US$114.7M | 466× | 1.8× | 12.4× | 0.9× | 0.6% | 0.1× | n/a |
| JW Holdings Corporation · KRX:096760 | US$187.0M | US$109.7M | 3.0× | 0.1× | 0.6× | 0.9× | 8.3% | 0.0× | n/a |
| NGL Fine-Chem Ltd. · NSE:NGLFINE | US$183.2M | US$183.2M | 29.7× | 3.2× | 20.2× | 5.2× | 10.7% | 0.0× | n/a |
| Beta Drugs Ltd. · NSE:BETA | US$181.1M | US$180.3M | 36.8× | 4.1× | 20.1× | 6.9× | 11.1% | 0.5× | n/a |
| Sinphar Pharmaceutical Co. Ltd. · TWSE:1734 | US$179.9M | US$193.6M | 16.9× | 1.9× | 9.6× | 1.7× | 10.2% | 0.6× | n/a |
| Golden Throat Holdings Group Co Ltd · HKEX:6896 | US$177.8M | US$121.9M | 4.7× | 0.9× | 2.4× | 1.0× | 26.6% | 0.6× | n/a |
| SIGA Technologies Inc. · NASDAQ:SIGA | US$172.5M | US$56.35M | 251× | 1.1× | n/a | 1.1× | 1.3% | 0.0× | 1.01 |
| Searle Company Ltd · PSX:SEARL | US$169.6M | US$163.7M | 68.6× | 1.2× | 6.4× | 1.4× | 1.8% | 0.0× | n/a |
| Dawnrays Pharmaceutical Holdings Ltd. · HKEX:2348 | US$165.1M | −US$72.72M | 5.2× | −0.4× | −1.4× | 0.3× | 17.4% | 0.0× | n/a |
| SCI Pharmtech Corp. · TWSE:4119 | US$164.3M | US$193.9M | 90.0× | 5.1× | 17.8× | 1.0× | 4.8% | 0.2× | n/a |
| Binh Dinh Pharmaceutical & Medical Equipment JSC · HOSE:DBD | US$161.0M | US$149.0M | 13.2× | 2.0× | 10.5× | 2.3× | 16.6% | 0.1× | n/a |
| Median of the others | US$175.1M | US$156.3M | 23.3× | 1.5× | 9.6× | 1.2× | 10.4% | 0.1× | 1.01 |
Events
| Quarter | Results |
|---|---|
| Q2 2025 | Sep 25, 2025 |
Financials
Annual, in CNY
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 432.5M | 607.8M | 556.4M | 349.1M |
| Cost of revenue | 104.6M | 116.4M | 98.9M | 81.7M |
| Gross profit | 327.9M | 491.4M | 457.5M | 267.5M |
| Research and development | 124.5M | 307.5M | 302.4M | 203.1M |
| Selling, general and administrative | 218.3M | 366.0M | 323.5M | 247.0M |
| Operating income | -6.89M | 21.0M | 22.7M | -70.5M |
| Depreciation and amortization | 68.5M | 48.3M | 42.4M | 33.9M |
| EBITDA | 61.6M | 69.3M | 65.1M | -36.5M |
| Interest expense | 2.54M | 8.99M | 13.2M | 13.7M |
| Income before tax | -13.4M | 19.2M | 22.4M | -70.6M |
| Net income | 2.48M | 21.1M | 31.7M | -49.4M |
| Earnings per share, basic | 0.01 | 0.05 | 0.08 | -0.12 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash and equivalents | 414.9M | 81.9M | 70.6M | 74.8M |
| Short-term investments | 238.3M | 266.1M | 330.8M | 346.1M |
| Receivables | 128.6M | 27.1M | 2.87M | 8.94M |
| Inventory | 36.7M | 47.2M | 36.1M | 28.3M |
| Current assets | 890.2M | 462.2M | 495.0M | 484.3M |
| Property, plant and equipment | 562.3M | 430.4M | 328.5M | |
| Total assets | 1.78B | 1.26B | 1.14B | 1.02B |
| Accounts payable | 21.4M | 20.6M | 27.2M | 13.1M |
| Current liabilities | 194.0M | 245.6M | 171.5M | 137.2M |
| Long-term debt | 97.8M | 55.4M | 19.2M | 0 |
| Total liabilities | 307.9M | 319.7M | 225.1M | 153.3M |
| Shareholders' equity | 1.47B | 939.3M | 910.0M | 861.9M |
| Shares outstanding | 411.9M | 412.0M | 412.0M | 412.0M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash from operations | -110.3M | 96.5M | 116.3M | 45.5M |
| Capital spending | -151.1M | -200.6M | -138.3M | -120.6M |
| Free cash flow | -261.4M | -104.2M | -22.0M | -75.1M |
| Cash from investing | -113.4M | -127.7M | -151.4M | |
| Cash from financing | 28.7M | 7.88M | -5.41M | |
| Share buybacks | -2.09M | 0 | ||
| Change in cash | 337.3M | 11.3M | -4.23M | -108.4M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026 | Nov 4, 2026 | Monthly return | HKEX |
| NEXT DAY DISCLOSURE RETURN | Oct 8, 2026 | Next day disclosure return | HKEX |
| NEXT DAY DISCLOSURE RETURN | Oct 7, 2026 | Next day disclosure return | HKEX |
| NEXT DAY DISCLOSURE RETURN | Oct 6, 2026 | Next day disclosure return | HKEX |
| Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026 | Oct 6, 2026 | Monthly return | HKEX |
| VOLUNTARY ANNOUNCEMENT VOLUNTARY EXTENSION OF LOCK-UP PERIOD FOR SHARES HELD BY CORE MANAGEMENT BY SIX MONTHS | Oct 5, 2026 | Other filings | HKEX |
| NEXT DAY DISCLOSURE RETURN | Oct 5, 2026 | Next day disclosure return | HKEX |
| NEXT DAY DISCLOSURE RETURN | Oct 2, 2026 | Next day disclosure return | HKEX |
| 2026 Interim Report | Sep 30, 2026 | Interim report | HKEX |
| NEXT DAY DISCLOSURE RETURN | Sep 30, 2026 | Next day disclosure return | HKEX |
All 16 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| NEXT DAY DISCLOSURE RETURN | Sep 29, 2026 | Next day disclosure return | HKEX |
| NEXT DAY DISCLOSURE RETURN | Sep 28, 2026 | Next day disclosure return | HKEX |
| VOLUNTARY ANNOUNCEMENT ICF004 COMPLETES ENROLMENT AND DOSING OF FIRST HEALTHY VOLUNTEER IN PHASE I CLINICAL TRIAL | Sep 21, 2026 | Other filings | HKEX |
| List of Directors and their Roles and Functions | Jun 26, 2026 | List of directors | HKEX |
| CHANGE IN BOARD LOT SIZE | Jun 22, 2026 | Other filings | HKEX |
| NEXT DAY DISCLOSURE RETURN | Jun 16, 2026 | Next day disclosure return | HKEX |
Cap table
Built by 6ix from CF PharmTech. Inc. Class H’s releases
- Common shares
- 322,381,086
- Fully diluted
- 322,381,086
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 322,381,086 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 322,381,086 |
Log in to ask 6ix AI your own questions about CF PharmTech. Inc.